Schroll Medical Aps
Schroll Medical ApS is an EU-GMP certified Danish medicinal cannabis manufacturer that breeds, cultivates, and packages proprietary cannabis flower cultivars and full spectrum extracts for white-label B2B supply to licensed wholesalers and distributors across Europe and Australia.
- Company typePrivate
- Founded2018
- HeadquartersDenmark, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Schroll Medical Aps does
Schroll Medical ApS is a Danish privately held pharmaceutical-grade medicinal cannabis manufacturer founded in 2018 by brothers Carsten Schroll (master grower) and Søren Schroll (finance and sales). The company breeds, cultivates, processes, laboratory-tests, and packages EU-GMP certified cannabis flowers (flos) and full spectrum extracts at production sites in Denmark (headquarters and breeding in Odense-area greenhouses) and Portugal (large-scale manufacturing via contract manufacturer Schroll Flavours). Its product portfolio consists of proprietary cultivars spanning THC-dominant (e.g., Big Purple Dragon, Godfather OG X, White Widow, Frosted Lemon Angel, Duke, Nordle, Cali Sunset), balanced THC/CBD (Thunderstruck), and CBD-dominant (Nightingale) variants, plus THC and balanced full spectrum extracts offered in 1 kg bulk bags and 10 g white-label jars.
The business model is exclusively B2B wholesale to licensed medicinal cannabis distributors and wholesalers, who resell under their own brands. Pricing is quote-based, undisclosed publicly, and structured around multi-year supply contracts; sales are handled by Head of Sales Thomas Kragh with a stated 2-day response time on inquiries. The company operates a vertically integrated value chain from proprietary genetics through packaging, and uses e-beam radiation decontamination instead of the more common gamma irradiation. Customers must be licensed medicinal cannabis distributors in their jurisdiction, and products are exported to 5 markets across Europe and Australia. The company holds EU-GMP certification, API certificates for both Denmark and Portugal, and authorizations to handle euphoriant substances and manufacture cannabis bulk and primary products. Schroll employs 40 people across the two countries and is privately funded, with no disclosed external institutional capital.
Schroll Medical Aps firmographics
Firmographics- Name
- Schroll Medical Aps
- Legal name
- Schroll Medical ApS
- Website
- https://schroll-medical.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Schroll Medical ApS is an EU-GMP certified Danish medicinal cannabis manufacturer that breeds, cultivates, and packages proprietary cannabis flower cultivars and full spectrum extracts for white-label B2B supply to licensed wholesalers and distributors across Europe and Australia.
- Ownership category
- akta.pro rank
Where Schroll Medical Aps is headquartered
LocationHeadquarters
- HQ city
- Denmark
- HQ country
- United States
- HQ region
- North America
Offices3 records
Markets served
Schroll Medical Aps business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- White-Label Medicinal Cannabis Products: B2B sales of EU-GMP certified medicinal cannabis flowers (flos) and full spectrum extracts to licensed distributors and wholesalers. Products are available as white-label solutions under customer brands. Includes bulk formats (1kg bags) and consumer-ready formats (10g jars). Also includes herbal extracts for diluted product formulations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B wholesale pricing for licensed distributors |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels3 records
Schroll Medical Aps product offering
Product offeringCore offering
Schroll Medical ApS is an EU-GMP certified breeder, cultivator, and manufacturer of medicinal cannabis flowers (flos) and full spectrum extracts, supplied on a white-label basis to licensed distributors and wholesalers in Europe and Australia. The company offers proprietary cannabis cultivars in THC-dominant, balanced, and CBD-dominant variants, available in 1kg bulk bags and 10g consumer jars, supported by in-house breeding, cultivation, drying, laboratory testing, and packaging operations in Denmark and Portugal.
Product overview
Schroll Medical Aps is an EU-GMP certified medicinal cannabis company offering a white label portfolio of pharmaceutical-grade cannabis products. The product portfolio consists of proprietary cannabis cultivars (flos/flower products and extracts) available in multiple formats including 1kg bulk bags, 10g consumer jars, and full spectrum oils. The company offers THC-dominant cultivars (Big Purple Dragon, Godfather OG X, White Widow, Frosted Lemon Angel, Duke, Nordle, Cali Sunset), balanced cultivars (Thunderstruck), and CBD-dominant cultivars (Nightingale), along with THC and THC/CBD full spectrum extracts. Products are standardized to pharmaceutical standards with full CoA release and are supplied to licensed wholesalers and distributors across Europe.
Differentiator
Problem solved
Functional benefit
Products and services
- Big Purple Dragon (Flos) THC-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- Godfather OG X (Flos) THC-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- White Widow (Flos) THC-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- Frosted Lemon Angel (Flos) THC-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- Duke (Flos) THC-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- Nordle (Flos) THC-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- Cali Sunset (Flos) THC-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- Thunderstruck (Flos) Balanced THC/CBD medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- Nightingale (Flos) CBD-dominant medicinal cannabis flower cultivar supplied by Schroll Medical as a white-label product in bulk or consumer-sized packaging to licensed distributors.
- THC Full Spectrum Extract Full spectrum cannabis oil extract with THC, available as a white-label solution for licensed medicinal cannabis distributors.
- THC/CBD Balanced Full Spectrum Extract Balanced full spectrum cannabis oil extract with equal THC and CBD content, available as a white-label solution for licensed medicinal cannabis distributors.
- Flos 1kg Bulk Bag 1kg bulk bag packaging format for medicinal cannabis flos intended for extraction or repacking into consumer-sized jars/bags, available irradiated or unirradiated.
- Flos 10g Jar (White Label) 10g white-label medicinal cannabis flower in consumer-ready jar packaging supplied to licensed distributors with the customer's own brand.
- Herbal Extract (Bulk Intermediate) Extracted cannabinoids in bulk intermediate format based on Schroll's proprietary cultivars, serving as a base for diluted product formulations.
Quantifiable outcome
- Products contain same active components year for year and batch for batch through EU-GMP certification
- +1 more outcomes
Companies that use Schroll Medical Aps
Customer profileSegments1 record
Ideal customer profiles1 record
Schroll Medical Aps technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Schroll Medical Aps partnerships and signals
Strategic signalScale indicators5 records
Recent moves9 records
Expansion highlights5 records
Schroll Medical Aps competitors and assessment
Company assessmentDirect peers
- Little Green Pharma: Australian medicinal cannabis producer with European expansion and EU-GMP certified supply. Comparable size, product focus on flower and extracts, and multi-jurisdiction go-to-market strategy.
- Cantourage: Berlin-based medicinal cannabis company distributing EU-GMP certified flower and extracts across Europe. Comparable B2B go-to-market, white-label approach, and product portfolio to Schroll.
- Bedrocan: Dutch medicinal cannabis producer with EU-GMP certification, supplying standardized cannabis flowers to pharmacies across Europe. Most comparable in regulatory profile and product focus on pharmaceutical-grade cannabis flower.
- Demecan: German EU-GMP certified medicinal cannabis producer cultivating and supplying flower and extracts. Direct competitor in the European medical cannabis wholesale space with similar B2B distributor model and product portfolio.
- Avextra: German medicinal cannabis producer with EU-GMP certification focused on THC and CBD cannabis extracts and flower. Comparable pharmaceutical-grade positioning and European B2B distribution model.
- Panaxia Pharmaceutical Industries: Israeli pharma-grade cannabis manufacturer producing EU-GMP certified medicinal cannabis products for European markets. Comparable pharmaceutical-grade production standards, white-label offering, and multi-jurisdiction distribution approach.
Broad incumbents
- Aurora Cannabis: Canadian cannabis multinational with EU-GMP production and distribution in Europe through its European medical division. Competes in medicinal cannabis flower and extracts but operates at much larger scale and broader portfolio.
- Tilray Medical: Medical division of Tilray, a major Canadian cannabis multinational with established European operations. Larger incumbent with overlapping EU-GMP flower and extract portfolio but much broader product range and balance sheet.
- Canopy Growth: Large Canadian cannabis company with European medical cannabis operations including EU-GMP supply through subsidiaries. Broader portfolio across recreational and medical, competing with Schroll on European medical flower and extract contracts.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights6 records
Customer concentration
Schroll Medical Aps social profiles
Digital presenceSchroll Medical Aps compliance and trust
Trust signalCompliance6 records
Schroll Medical Aps financial estimates
Financial estimateRevenue estimate
Valuation estimate
Schroll Medical Aps leadership team
Management profileNumber of profiles
Profiles3 records
Schroll Medical Aps funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Schroll Medical Aps M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Schroll Medical Aps
What does Schroll Medical Aps do?
Schroll Medical ApS is an EU-GMP certified breeder, cultivator, and manufacturer of medicinal cannabis flowers (flos) and full spectrum extracts, supplied on a white-label basis to licensed distributors and wholesalers in Europe and Australia. The company offers proprietary cannabis cultivars in THC-dominant, balanced, and CBD-dominant variants, available in 1kg bulk bags and 10g consumer jars, supported by in-house breeding, cultivation, drying, laboratory testing, and packaging operations in Denmark and Portugal.
Is Schroll Medical Aps a public or private company?
Schroll Medical Aps is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Schroll Medical Aps founded?
Schroll Medical Aps was founded in 2018. It employs 11 to 50 people.
Where is Schroll Medical Aps based?
Schroll Medical Aps is headquartered in Denmark, United States, in the North America region.
How does Schroll Medical Aps make money?
One revenue line is on record: white-Label Medicinal Cannabis Products.
Who are Schroll Medical Aps's main competitors?
Direct peers on record are Little Green Pharma, Cantourage, Bedrocan, Demecan, Avextra and Panaxia Pharmaceutical Industries. Broad incumbents are Aurora Cannabis, Tilray Medical and Canopy Growth.
Does Schroll Medical Aps have an API?
No public API is recorded for Schroll Medical Aps.